Scotland rebuffs Kymriah for DLBCL, backs it for ALL

Scottish Medicines Consortium (SMC) did not recommend Novartis' Kymriah tisagenlecleucel for use within NHS Scotland for adults

Read the full 179 word article

User Sign In